Molecular modelling, synthesis and in vitro evaluation of quinazolinone hybrid analogues as potential pancreatic lipase inhibitors

References

• Ajeet, K., Reddy, P. V., Kumar, T. R., Singh, M., Singh, K., Shukla, M., Yadav, A., Dogra, S., Sona, C., Umrao, D., Jaiswal, S., Ahmad, H., Rashid, M., Singh, S. K., Wahajuddin, M., Dwivedi, A. K., Siddiqi, M. I., Lal, J., Tripathi, R. P., & Yadav, P. N. (2019). Novel tetrahydroquinazolinamines as selective histamine 3 receptor antagonists for the treatment of obesity. Journal of Medicinal Chemistry, 62(9), 4638–4655. https://doi.org/10.1021/acs.jmedchem.9b00241
   PubMed Web of Science ®Google Scholar
• Asundaria, S. T., Patel, N. S., & Patel, K. C. (2012). Synthesis, characterization, and antimicrobial studies of novel 1,3,4-thiadiazolium-5-thiolates. Medicinal Chemistry Research, 21(7), 1199–1206. https://doi.org/10.1007/s00044-011-9632-2
   Web of Science ®Google Scholar
• Balaji, M., Ganjayi, M. S., Hanuma Kumar, G. E. N., Parim, B. N., Mopuri, R., & Dasari, S. (2016). A review on possible therapeutic targets to contain obesity: The role of phytochemicals. Obesity Research & Clinical Practice, 10(4), 363–380. https://doi.org/10.1016/J.ORCP.2015.12.004
   PubMed Web of Science ®Google Scholar
• Banerjee, P., Eckert, A. O., Schrey, A. K., & Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46(W1), W257–W263. https://doi.org/10.1093/NAR/GKY318
   PubMed Web of Science ®Google Scholar
• Bhat, S. P., & Sharma, A. (2017). Current drug targets in obesity pharmacotherapy—A review. Current Drug Targets, 18(8), 983–993. https://doi.org/10.2174/1389450118666170227153940
   PubMed Web of Science ®Google Scholar
• Burlingham, B. T., & Widlanski, T. S. (2003). An intuitive look at the relationship of Ki and IC50: A more general use for the Dixon plot. Journal of Chemical Education, 80(2), 214. https://doi.org/10.1021/ed080p214
   Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). AdmetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/CI300367A
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717–42713. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Daneschvar, H. L., Aronson, M. D., & Smetana, G. W. (2016). FDA-approved anti-obesity drugs in the United States. The American Journal of Medicine, 129(8), 879.e1-879–e6. https://doi.org/10.1016/j.amjmed.2016.02.009
   Web of Science ®Google Scholar
• Egloff, M. P., Marguet, F., Buono, G., Verger, R., Cambillau, C., & van Tilbeurgh, H. (1995). The 2.46 Å resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry, 34(9), 2751–2762. https://doi.org/10.1021/bi00009a003
   PubMed Web of Science ®Google Scholar
• Filippatos, T. D., Derdemezis, C. S., Gazi, I. F., Nakou, E. S., Mikhailidis, D. P., & Elisaf, M. S. (2008). Orlistat-associated adverse effects and drug interactions: A critical review. Drug Safety, 31(1), 53–65. https://doi.org/10.2165/00002018-200831010-00005
   PubMed Web of Science ®Google Scholar
• George, G., Auti, P., & Paul, A. T. (2021). Design, synthesis, in silico molecular modelling studies and biological evaluation of novel indole-thiazolidinedione hybrid analogues as potential pancreatic lipase inhibitors. New Journal of Chemistry, 45(3), 1381–1394. https://doi.org/10.1039/D0NJ05649A
   Web of Science ®Google Scholar
• George, G., Auti, P. S., & Paul, A. T. (2021). Design, synthesis and biological evaluation of N-substituted indole-thiazolidinedione analogues as potential pancreatic lipase inhibitors. Chemical Biology & Drug Design, 98(1), 49–59. https://doi.org/10.1111/CBDD.13846
   PubMed Web of Science ®Google Scholar
• George, G., Sengupta, P., & Paul, A. T. (2020). Optimisation of an extraction conditions for Rumex nepalensis anthraquinones and its correlation with Pancreatic Lipase inhibitory activity. Journal of Food Composition and Analysis, 92, 103575. https://doi.org/10.1016/j.jfca.2020.103575
   Web of Science ®Google Scholar
• Hadvary, P., Lengsfeld, H., & Wolfer, H. (1988). Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. The Biochemical Journal, 256(2), 357–361. https://doi.org/10.1042/bj2560357
   PubMed Web of Science ®Google Scholar
• Hadvary, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991). The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. Journal of Biological Chemistry, 266(4), 2021–2027. https://doi.org/10.1016/S0021-9258(18)52203-1
   PubMed Web of Science ®Google Scholar
• Hruby, A., & Hu, F. B. (2015). The epidemiology of obesity: A big picture. PharmacoEconomics, 33(7), 673–689. https://doi.org/10.1007/S40273-014-0243-X
   PubMed Web of Science ®Google Scholar
• Kalibaeva, G., Ferrario, M., & Ciccotti, G. (2003). Constant pressure-constant temperature molecular dynamics: A correct constrained NPT ensemble using the molecular virial. Molecular Physics, 101(6), 765–778. https://doi.org/10.1080/0026897021000044025
   Web of Science ®Google Scholar
• Kumar, A., & Chauhan, S. (2021). Pancreatic lipase inhibitors: The road voyaged and successes. Life Sciences, 271, 119115. https://doi.org/10.1016/J.LFS.2021.119115
   PubMed Web of Science ®Google Scholar
• Lineweaver, H., & Burk, D. (1934). The determination of enzyme dissociation constants. Journal of the American Chemical Society, 56(3), 658–666. https://doi.org/10.1021/ja01318a036
   Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/10.1016/J.DDTEC.2004.11.007
   PubMedGoogle Scholar
• Liu, T. T., Liu, X. T., Chen, Q. X., & Shi, Y. (2020). Lipase inhibitors for obesity: A review. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 128, 110314. https://doi.org/10.1016/j.biopha.2020.110314
   PubMed Web of Science ®Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Markham, A. (2021). Setmelanotide: First approval. Drugs, 81(3), 397–403. https://doi.org/10.1007/S40265-021-01470-9
   PubMed Web of Science ®Google Scholar
• Menteşe, E., Karaali, N., Akyüz, G., Yılmaz, F., Ülker, S., & Kahveci, B. (2016). Synthesis and evaluation of α-glucosidase and pancreatic lipase inhibition by quinazolinone-coumarin hybrids. Chemistry of Heterocyclic Compounds, 52(12), 1017–1024. https://doi.org/10.1007/s10593-017-2002-3
   Web of Science ®Google Scholar
• Modanwal, S., & Mishra, N. (2021). Identification of common genes in obesity and cancer through network interaction and targeting those genes by virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/10.1080/07391102.2021.2020169
   Google Scholar
• Modh, P. G., & Patel, L. J. (2021). Synthesis, drug likeness and in-vitro screening of some novel quinazolinone derivatives for anti-obesity activity. Journal of Pharmaceutical Research International, 33(28B), 81–92. https://doi.org/10.9734/jpri/2021/v33i28B31541
   Web of Science ®Google Scholar
• Montero, J. L., Muntané, J., Fraga, E., Delgado, M., Costán, G., Serrano, M., Padillo, J., de la Mata, M., & Miño, G. (2001). Orlistat associated subacute hepatic failure. Journal of Hepatology, 34(1), 173. https://doi.org/10.1016/S0168-8278(00)00042-8
   PubMed Web of Science ®Google Scholar
• Pedgaonkar, G. S., Sridevi, J. P., Jeankumar, V. U., Saxena, S., Devi, P. B., Renuka, J., Yogeeswari, P., & Sriram, D. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613–627. https://doi.org/10.1016/J.EJMECH.2014.09.028
   PubMed Web of Science ®Google Scholar
• Rajan, L., Palaniswamy, D., & Mohankumar, S. K. (2020). Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review. Pharmacological Research, 155, 104681. https://doi.org/10.1016/j.phrs.2020.104681
   PubMed Web of Science ®Google Scholar
• Riadi, Y., Alamri, M. A., Geesi, M. H., Anouar, E. H., Ouerghi, O., Alabbas, A. B., Alossaimi, M. A., Altharawi, A., Dehbi, O., & Alqahtani, S. M. (2022). Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases. Journal of Biomolecular Structure and Dynamics, 1–7, 40(15), 6810–6816. https://doi.org/10.1080/07391102.2021.1890221
   PubMed Web of Science ®Google Scholar
• Rim, K. T. (2020). In silico prediction of toxicity and its applications for chemicals at work. Toxicology and Environmental Health Sciences, 12(3), 191–202. https://doi.org/10.1007/s13530-020-00056-4
   PubMed Web of Science ®Google Scholar
• Rudolph, J., Esler, W. P., O’connor, S., Coish, P. D. G., Wickens, P. L., Brands, M., Bierer, D. E., Bloomquist, B. T., Bondar, G., Chen, L., Chuang, C.-Y., Claus, T. H., Fathi, Z., Fu, W., Khire, U. R., Kristie, J. A., Liu, X.-G., Lowe, D. B., Mcclure, A. C., … Bullock, W. H. (2007). Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. Journal of Medicinal Chemistry, 50(21), 5202-5216. https://doi.org/10.1021/JM070071
   Google Scholar
• Sridhar, S. N. C., Sengupta, P., Palawat, S., Dileep, P. S., George, G., & Paul, A. T. (2021). Synthesis, molecular modelling, in vitro and in vivo evaluation of conophylline inspired novel benzyloxy substituted indole glyoxylamides as potent pancreatic lipase inhibitors. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2021.1930168
   Web of Science ®Google Scholar
• Sasmal, S., Balaji, G., Kanna Reddy, H. R., Balasubrahmanyam, D., Srinivas, G., Kyasa, S., Sasmal, P. K., Khanna, I., Talwar, R., Suresh, J., Jadhav, V. P., Muzeeb, S., Shashikumar, D., Harinder Reddy, K., Sebastian, V. J., Frimurer, T. M., Rist, Ø., Elster, L., & Högberg, T. (2012). Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorganic & Medicinal Chemistry Letters, 22(9), 3157–3162. https://doi.org/10.1016/j.bmcl.2012.03.050
   PubMed Web of Science ®Google Scholar
• Schenkel, L. B., Olivieri, P. R., Boezio, A. A., Deak, H. L., Emkey, R., Graceffa, R. F., Gunaydin, H., Guzman-Perez, A., Lee, J. H., Teffera, Y., Wang, W., Youngblood, B. D., Yu, V. L., Zhang, M., Gavva, N. R., Lehto, S. G., & Geuns-Meyer, S. (2016). Optimization of a novel quinazolinone-based series of transient receptor potential A1 (TRPA1) antagonists demonstrating potent in vivo activity. Journal of Medicinal Chemistry, 59(6), 2794–2809. https://doi.org/10.1021/acs.jmedchem.6b00039
   PubMed Web of Science ®Google Scholar
• Sridhar, S. N. C., George, G., Verma, A., & Paul, A. T. (2019). Natural products-based pancreatic lipase inhibitors for obesity treatment. In Natural Bio-active Compounds (pp. 149–191). Springer. https://doi.org/10.1007/978-981-13-7154-7_6
   Google Scholar
• Sun, J., Tao, T., Xu, D., Cao, H., Kong, Q., Wang, X., Liu, Y., Zhao, J., Wang, Y., & Pan, Y. (2018). Metal-free oxidative cyclization of 2-amino-benzamides, 2-aminobenzenesulfonamide or 2-(aminomethyl)anilines with primary alcohols for the synthesis of quinazolinones and their analogues. Tetrahedron Letters, 59(21), 2099–2102. https://doi.org/10.1016/j.tetlet.2018.04.054
   Web of Science ®Google Scholar
• Thomsen, R., & Christensen, M. H. (2006). MolDock: A new technique for high-accuracy molecular docking. Journal of Medicinal Chemistry, 49(11), 3315–3321. https://doi.org/10.1021/jm051197e
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (2021). FDA Approves New Drug Treatment for Chronic Weight Management
   Google Scholar
• Valsamakis, G., Konstantakou, P., & Mastorakos, G. (2017). New targets for drug treatment of obesity. Annual Review of Pharmacology and Toxicology, 57(1), 585–605. https://doi.org/10.1146/annurev-pharmtox-010716-104735
   PubMedGoogle Scholar
• van Tilbeurgh, H., Egloff, M.-P., Martinez, C., Rugani, N., Verger, R., & Cambillau, C. (1993). Interfacial activation of the lipase–procolipase complex by mixed micelles revealed by X-ray crystallography. Nature, 362(6423), 814–820. https://doi.org/10.1038/362814a0
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) (2018). Obesity and overweight. Fact Sheets.
   Google Scholar
• World Health Organization (WHO) (2020). Cancer.
   Google Scholar
• Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019). AdmetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics (Oxford, England), 35(6), 1067–1069. https://doi.org/10.1093/BIOINFORMATICS/BTY707
   PubMed Web of Science ®Google Scholar
• Zang, Q., Mansouri, K., Williams, A. J., Judson, R. S., Allen, D. G., Casey, W. M., & Kleinstreuer, N. C. (2017). In silico prediction of physicochemical properties of environmental chemicals using molecular fingerprints and machine learning. Journal of Chemical Information and Modeling, 57(1), 36–49. https://doi.org/10.1021/acs.jcim.6b00625
   PubMed Web of Science ®Google Scholar